Literature DB >> 359850

Therapy and prophylaxis of malaria.

G H Trenholme, P E Carson.   

Abstract

Physicians should be prepared to provide prophylactic medications for travelers to malarious areas and to treat patients with malaria. Chloroquine hydrochloride is the suppressive agent of choice for treatment of mild infections due to all species of malaria except for those due to chloroquine-resistant strains of Plasmodium falciparum. For treatment of severe infections with P falficparum, quinine is the suppressive agent of choice. Chloroquine is also the prophylactic agent of choice for most travelers. To prevent infection with P vivax or P ovale, primaquine must also be given. A RBC glucose-6-phosphate dehydrogenase level should be obtained before administration of primaquine. For prophylaxis of chloroquine-resistant strains of P falciparum, no completely satisfactory regimen is presently available in the United States.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 359850

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug.

Authors:  D F Clyde
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

2.  Caring for Southeast Asian refugee patients in the USA.

Authors:  M A Muecke
Journal:  Am J Public Health       Date:  1983-04       Impact factor: 9.308

3.  Predictive modeling of anti-malarial molecules inhibiting apicoplast formation.

Authors:  Salma Jamal; Vinita Periwal; Vinod Scaria
Journal:  BMC Bioinformatics       Date:  2013-02-15       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.